Format

Send to

Choose Destination
See comment in PubMed Commons below
Rev Med Inst Mex Seguro Soc. 2008 Nov-Dec;46(6):603-10.

[Candiduria in type 2 diabetes mellitus patients and its clinical significance. Candida spp. antifungal susceptibility].

[Article in Spanish]

Author information

1
Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México. angelesmg@liceaga.facmed.unam.mx

Abstract

BACKGROUND:

Candida is frequently seen in urinalysis studies in patients with diabetes mellitus. The objective was to determine the presence and clinical significance of candiduria, and to identify the different isolated Candida species and their in vitro susceptibility pattern to different antifungal agents by means of the broth microdilution method.

METHODS:

We studied the urine from 50 type 2 diabetes mellitus (DMT2) patients. 24 patients had controlled DMT2 and 26 non-controlled DMT2.

RESULTS:

Twenty-three Candida spp. positive cultures were obtained, of which 17 were obtained from the non-controlled DMT2 patients; 30.7% of the isolates were caused by Candida infection. The main isolated species were C. glabrata (48%) and C. albicans (35%). Itraconazole, amphotericine B, and ketoconazole showed less antifungal activity in C. glabrata isolates, whereas fluconazole and voriconazole displayed higher antifungal activity.

CONCLUSIONS:

It is important to search routinely for yeast in the urine of DMT2 patients to detect candidiasis, and to perform antifungal susceptibility tests to Candida isolates in order to establish antifungal therapy for these patients.

PMID:
19263663
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center